Advertisement
Person › Details
Andreas Grassauer (Marinomed Biotechnologie GmbH)
Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO)
Organisation | Marinomed Biotechnologie GmbH | |
Today | Marinomed Biotech AG (VSE: MARI) | |
Group | Marinomed Biotech AG (VSE: MARI) | |
Product | virostatic agent | |
Record changed: 2022-01-21 |
Advertisement
More documents for Andreas Grassauer
- [1] Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg....
- [2] Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna....
- [3] Marinomed Biotech AG. (11/28/18). "Press Release: Viennese Biotech Company Marinomed Demonstrates the Benefits of Its Patented Marinosolv Technology"....
- [4] Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna....
- [5] Marinomed Biotech AG. (8/29/18). "Press Release: Vienna-based Biotech Company Marinomed on a Growth Path"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top